Literature DB >> 10328097

Arsenic trioxide, a novel mitochondriotoxic anticancer agent?

G Kroemer, H de Thé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10328097     DOI： 10.1093/jnci/91.9.743

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Sandeep Sreevalsan; Ping Lei; Rola Barhoumi; Robert Burghardt; Stephen Safe
Journal:  Exp Cell Res       Date:  2010-05-08       Impact factor: 3.905

Review 2.  PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Nucleus       Date:  2014       Impact factor: 4.197

3.  Nitric oxide and calcium ions in apoptotic esophageal carcinoma cells induced by arsenite.

Authors:  Zhong-Ying Shen; Wen-Ying Shen; Ming-Hua Chen; Jian Shen; Wei-Jie Cai; Zeng Yi
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 4.  How animal models of leukaemias have already benefited patients.

Authors:  Julien Ablain; Rihab Nasr; Jun Zhu; Ali Bazarbachi; Valérie Lallemand-Breittenbach; Hugues de Thé
Journal:  Mol Oncol       Date:  2013-02-11       Impact factor: 6.603

5.  Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.

Authors:  Majid Momeny; Majid Zakidizaji; Reza Ghasemi; Ahmad R Dehpour; Maryam Rahimi-Balaei; Yassan Abdolazimi; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed H Ghaffari
Journal:  Med Oncol       Date:  2009-09-10       Impact factor: 3.064

6.  Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA.

Authors:  Lionel Berthoux; Sarah Sebastian; Elena Sokolskaja; Jeremy Luban
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.

Authors:  Hecheng Li; Xiaoli Zhu; Yawei Zhang; Jiaqing Xiang; Haiquan Chen
Journal:  J Exp Clin Cancer Res       Date:  2009-08-08

8.  Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.

Authors:  Yayoi Yoshimura; Akihiko Shiino; Kazue Muraki; Tadateru Fukami; Shigeki Yamada; Takeshi Satow; Miyuki Fukuda; Masaaki Saiki; Masato Hojo; Susumu Miyamoto; Nobuyuki Onishi; Hideyuki Saya; Toshiro Inubushi; Kazuhiko Nozaki; Kenji Tanigaki
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

9.  The roles of mitoferrin-2 in the process of arsenic trioxide-induced cell damage in human gliomas.

Authors:  Chunlei Wang; Xiaofeng Chen; Huichao Zou; Xin Chen; Yaohua Liu; Shiguang Zhao
Journal:  Eur J Med Res       Date:  2014-09-26       Impact factor: 2.175

10.  Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.

Authors:  Anam Akhtar; Lucy Ghali; Scarlet Xiaoyan Wang; Celia Bell; Dong Li; Xuesong Wen
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.